Minerva Neurosciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $69.1M | $77.1M | $60.8M |
| FY2022 | $75.1M | $55.1M | $36.1M |
| FY2023 | $85.4M | $56.9M | $40.9M |
| FY2024 | $62.8M | $37.1M | $21.4M |
| FY2025 | $233.8M | $98.0M | $82.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $69.1M | $77.1M | $60.8M |
| FY2022 | $75.1M | $55.1M | $36.1M |
| FY2023 | $85.4M | $56.9M | $40.9M |
| FY2024 | $62.8M | $37.1M | $21.4M |
| FY2025 | $233.8M | $98.0M | $82.3M |